← SynDRA
MEGLUMINE
SynDRA canonical compound SYN0023061 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Mechanism of action | excipient |
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Contrast Media
- Diagnostic Uses of Chemicals
- excipient
Cross-references
Synonyms
- ISOPAQUE 280
- Meglumina
- N-methylglucamine
- D(-)-n-methylglucamine
- Megluminum
- Methylglucamine
- N-methylsorbitylamine
- NSC-52907
- NSC-7391
- N-Methyl-D-glucamine
- N-Methylsorbitylamine
- D-Glucitol, 1-deoxy-1-(methylamino)-
- 1-Deoxy-1-methylaminosorbitol
- N-Methyl-D(-)-glucamine
- d(-)-n-methylglucamine
- 1-deoxy-1-methylamino-d-glucitol
- 6HG8UB2MUY
- D-(-)-N-Methylglucamine
- NSC 7391
- NSC 52907
- CHEBI:59732
- NSC52907
- NSC7391
- antimoniate de mAglumine
- RefChem:389110
- GlyTouCan:G20950LN
- P01CB01
- G20950LN
- N-Methylglucamine
- Meglumin
- 1-Deoxy-1-(methylamino)-D-glucitol
- C7H17NO5
- Sorbitol, 1-deoxy-1-methylamino-
- MFCD00004707
- Megluminum [INN-Latin]
- Meglumina [INN-Spanish]
- Glucitol, 1-deoxy-1-(methylamino)-, D-
- DTXCID503244
Look up MEGLUMINE in the interactive SynDRA portal →